79 related articles for article (PubMed ID: 35122589)
1. Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.
Uson PLS; Samadder NJ; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Kunze K; Golafshar M; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00414. PubMed ID: 34620795
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
3. Germline Genetic Testing in Unselected Squamous and Non-Squamous Head and Neck Cancers.
Brake DA; Idler BM; Kunze KL; Golafshar MA; Heald B; Young S; Klint M; Barrus K; Esplin ED; Nussbaum RL; Samadder NJ; Hinni ML; Chang BA
Laryngoscope; 2023 Dec; 133(12):3378-3388. PubMed ID: 37132629
[TBL] [Abstract][Full Text] [Related]
4. Rate of Pathogenic Germline Variants in Patients With Lung Cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract][Full Text] [Related]
5. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
Shelton C; Ruiz A; Shelton L; Montgomery H; Freas K; Ellsworth RE; Poll S; Pineda-Alvarez D; Heald B; Esplin ED; Nielsen SM
Ann Surg Oncol; 2024 Jan; 31(1):325-334. PubMed ID: 37814187
[TBL] [Abstract][Full Text] [Related]
6. Upper Gastrointestinal Cancers and the Role of Genetic Testing.
Harrold EC; Stadler ZK
Hematol Oncol Clin North Am; 2024 Jun; 38(3):677-691. PubMed ID: 38458854
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.
Koster R; Schipper LJ; Giesbertz NAA; van Beek D; Mendeville M; Samsom KG; Rosenberg EH; Hogervorst FBL; Roepman P; Boelens MC; Bosch LJW; van den Berg JG; Meijer GA; Voest EE; Cuppen E; Ruijs MWG; van Wezel T; van der Kolk L; Monkhorst K
Genet Med; 2024 Feb; 26(2):101032. PubMed ID: 38006283
[TBL] [Abstract][Full Text] [Related]
8. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
Laguna JC; Pastor B; Nalda I; Hijazo-Pechero S; Teixido C; Potrony M; Puig-Butillé JA; Mezquita L
Br J Cancer; 2024 May; 130(9):1420-1431. PubMed ID: 38532104
[TBL] [Abstract][Full Text] [Related]
9. Willingness to undergo screening gastroscopy in a population with low-to-moderate prevalence rate of esophageal and gastric cancer.
Budzyń K; Pelczar M; Romańczyk M; Barański K; Hartleb M
Pol Arch Intern Med; 2024 Feb; 134(2):. PubMed ID: 38258699
[No Abstract] [Full Text] [Related]
10. Most patients with cancer are not undergoing germline genetic testing.
Fillon M
CA Cancer J Clin; 2024; 74(1):6-7. PubMed ID: 38240706
[No Abstract] [Full Text] [Related]
11. Prenatal and pre-implantation genetic testing for monogenic disorders for germline cancer susceptibility gene variants: UK joint consensus guidance.
Wafik M; Kilby MD; Kulkarni A;
BJOG; 2023 Dec; 130(13):1563-1567. PubMed ID: 37334763
[No Abstract] [Full Text] [Related]
12. Key New Studies in Gastric and Esophageal Cancer.
Chang DT; Jabbour SK; Brunner T; Cheng JC; Liauw SL; Meyer J; Wo J
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):475-81. PubMed ID: 26460987
[No Abstract] [Full Text] [Related]
13. Gastric Cancer Risk and Pathogenesis in
Buckley KH; Niccum BA; Maxwell KN; Katona BW
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497436
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience.
Calvello M; Marabelli M; Gandini S; Marino E; Bernard L; Dal Molin M; Di Cola G; Zanzottera C; Corso G; Fazio N; Gervaso L; Fumagalli Romario U; Barberis M; Guerrieri-Gonzaga A; Bertario L; Serrano D; Bonanni B
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239438
[TBL] [Abstract][Full Text] [Related]
15. BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Petrelli A; Rizzolio S; Pietrantonio F; Bellomo SE; Benelli M; De Cecco L; Romagnoli D; Berrino E; Orrù C; Ribisi S; Moya-Rull D; Migliore C; Conticelli D; Maina IM; Puliga E; Serra V; Pellegrino B; Llop-Guevara A; Musolino A; Siena S; Sartore-Bianchi A; Prisciandaro M; Morano F; Antista M; Fumagalli U; De Manzoni G; Degiuli M; Baiocchi GL; Amisano MF; Ferrero A; Marchiò C; Corso S; Giordano S
Cancer Res; 2023 May; 83(10):1699-1710. PubMed ID: 37129948
[TBL] [Abstract][Full Text] [Related]
16. Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.
Uson PLS; Kunze KL; Golafshar MA; Botrus G; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Kahn A; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T; Samadder NJ
Dig Dis Sci; 2022 Nov; 67(11):5107-5115. PubMed ID: 35122589
[TBL] [Abstract][Full Text] [Related]
17. Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study.
Uson Junior PL; Kunze KL; Golafshar MA; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Barrus K; Mountjoy L; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T; Samadder NJ
Cancer Prev Res (Phila); 2022 Feb; 15(2):121-128. PubMed ID: 34782326
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
Samadder NJ; Riegert-Johnson D; Boardman L; Rhodes D; Wick M; Okuno S; Kunze KL; Golafshar M; Uson PLS; Mountjoy L; Ertz-Archambault N; Patel N; Rodriguez EA; Lizaola-Mayo B; Lehrer M; Thorpe CS; Yu NY; Esplin ED; Nussbaum RL; Sharp RR; Azevedo C; Klint M; Hager M; Macklin-Mantia S; Bryce AH; Bekaii-Saab TS; Sekulic A; Stewart AK
JAMA Oncol; 2021 Feb; 7(2):230-237. PubMed ID: 33126242
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
